Premium
Edesa Biotech Inc (EDSA)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-i... Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients. Show more
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0601 | -3.24829748135 | 1.8502 | 1.9 | 1.55 | 12128 | 1.73964023 | CS |
| 4 | -0.6899 | -27.8185483871 | 2.48 | 2.55 | 1.55 | 30122 | 1.98463118 | CS |
| 12 | -2.4099 | -57.3785714286 | 4.2 | 4.54 | 1.55 | 32105 | 2.73686997 | CS |
| 26 | -2.4599 | -57.88 | 4.25 | 5.59 | 1.55 | 18679 | 3.14072712 | CS |
| 52 | -3.3199 | -64.9686888454 | 5.11 | 5.99 | 1.55 | 15362 | 3.7375889 | CS |
| 156 | -43.5699 | -96.0535714286 | 45.36 | 45.43 | 1.55 | 104625 | 11.02778919 | CS |
| 260 | -26.2799 | -93.6227288921 | 28.07 | 133.7 | 1.55 | 384935 | 54.27167685 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
